about
Immunization of HLA class I transgenic mice identifies autoantigenic epitopes eliciting dominant responses in type 1 diabetes patients.The infiltration kinetics of simian immunodeficiency virus-specific T cells drawn to sites of high antigenic stimulation determines local in vivo viral escape.Penicillin binding proteins as danger signals: meningococcal penicillin binding protein 2 activates dendritic cells through Toll-like receptor 4.PRA1 co-localizes with envelope but does not influence primate lentivirus production, infectivity or envelope incorporation.Immunoregulatory properties of heme oxygenase-1.Heme oxygenase and carbon monoxide as an immunotherapeutic approach in transplantation and cancer.Heme Oxygenase-1 Modulates Human Respiratory Syncytial Virus Replication and Lung Pathogenesis during Infection.HLA class I epitope discovery in type 1 diabetes.Carbon monoxide inhibits TLR-induced dendritic cell immunogenicity.Carbon monoxide decreases endosome-lysosome fusion and inhibits soluble antigen presentation by dendritic cells to T cells.β2-Adrenoreceptor agonist inhibits antigen cross-presentation by dendritic cells.Novel AIDS vaccine approach using epithelial stem cells as mucosal antigen-presenting cells.Epithelial stem cells as mucosal antigen-delivering cells: a novel preventive approach.Equivalent specificity of peripheral blood and islet-infiltrating CD8+ T lymphocytes in spontaneously diabetic HLA-A2 transgenic NOD mice.Inhibition of effector antigen-specific T cells by intradermal administration of heme oxygenase-1 inducers.Carbon monoxide-treated dendritic cells decrease β1-integrin induction on CD8+T cells and protect from type 1 diabetesGenetic Restoration of Heme Oxygenase-1 Expression Protects from Type 1 Diabetes in NOD MiceCD8+ T-cell responses identify beta-cell autoimmunity in human type 1 diabetesThe frequency and immunodominance of islet-specific CD8+ T-cell responses change after type 1 diabetes diagnosis and treatmentEditorial: Heme oxygenase-1 and dendritic cells: what else?Pancreatic nerve electrostimulation inhibits recent-onset autoimmune diabetes
P50
Q33285140-CA24519C-1E14-42C0-AEFC-21E5FEA91338Q33949260-B5CB9230-6552-4EF6-90F9-104A9C501DEEQ34064278-33FD4874-E79C-486F-BA91-6B13E76F520DQ34421251-7362FF5A-8305-41FB-ACF8-BB7D4E8B615AQ37799749-0925F820-27EE-4D34-A8F5-DC97B09F954CQ37869485-257D8982-6EC5-4A9F-82BC-E576B0EB5DD9Q38752668-4555FAC6-9712-4497-B0C4-21B63368D0DDQ40203831-9F10522F-E609-45C9-A7BC-6974E571C795Q44199735-4A4153A2-16F5-49A5-9818-F9F3C6341C3BQ44622580-5AC15A9E-CED7-4DD8-B236-04D7C0ECEEAFQ46738225-1727372C-49B3-45D9-A7FC-9122B9D5FC9CQ46989976-9F109293-D9A5-4981-B861-9FCD7D4E0795Q47097219-8F8437F8-5ACC-4EE9-8EE2-03923EB930E0Q51707718-A6452BF6-5085-4C32-BE99-598DEB01C1F4Q52886779-02C6451D-29E3-4753-B9FE-B08F7F9A4478Q58158657-12679BDB-0CC7-40B4-A49D-24B0ECE9B3DBQ64080377-F8BE8712-D413-4C37-AAB6-8EA182AD0DD5Q79843146-97B2AAC9-3B19-48D6-9A9E-A3A08E91EFD1Q80785961-B65BC30A-30CC-4B4F-8340-93EB2C024A50Q82741233-7599CBF3-D09D-4734-956C-CB6081A1C549Q91236219-136F5AFB-AE41-4D72-96BE-E755231D36C6
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Philippe Blancou
@ast
Philippe Blancou
@en
Philippe Blancou
@es
Philippe Blancou
@nl
Philippe Blancou
@sl
type
label
Philippe Blancou
@ast
Philippe Blancou
@en
Philippe Blancou
@es
Philippe Blancou
@nl
Philippe Blancou
@sl
prefLabel
Philippe Blancou
@ast
Philippe Blancou
@en
Philippe Blancou
@es
Philippe Blancou
@nl
Philippe Blancou
@sl
P106
P31
P496
0000-0003-0305-8622